964952999	964952999	CD	B-NP	O
|	|	NN	I-NP	O
BMH	BMH	NN	I-NP	O
|	|	NN	I-NP	O
16017605	16017605	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
942145	942145	CD	B-NP	O
|	|	CC	I-NP	O
2/26/2001	2/26/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/1/2001	2/1/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/6/2001	1/6/2001	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
AND	AND	CC	I-NP	O
ATRIAL	ATRIAL	NNP	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CONGESTIVE	CONGESTIVE	NNP	B-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
ATRIAL	ATRIAL	NNP	B-NP	O
FIBRILLATION	FIBRILLATION	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
SIGNIFICANT	SIGNIFICANT	NNP	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
non	non	JJ	B-NP	O
insulin	insulin	NN	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
Spanish	Spanish	JJ	I-NP	O
speaking	speaking	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
and	and	CC	O	O
extensive	extensive	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
long-standing	long-standing	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
non	non	JJ	B-NP	O
insulin	insulin	NN	I-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
since	since	IN	B-PP	O
1995	1995	CD	B-NP	O
with	with	IN	B-PP	O
hemoglobin	hemoglobin	NN	B-NP	B-protein
AIC	AIC	NN	I-NP	O
of	of	IN	B-PP	O
10.5	10.5	CD	B-NP	O
on	on	IN	B-PP	O
11/16/01	11/16/01	CD	B-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
smoking	smoking	NN	I-NP	O
history	history	NN	I-NP	O
and	and	CC	I-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
brothers	brother	NNS	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
46	46	CD	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
his	his	PRP$	B-NP	O
first	first	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
1990	1990	CD	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
22	22	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dyskinetic	dyskinetic	JJ	I-NP	O
apex	apex	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
August	August	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
another	another	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
at	at	IN	B-PP	O
Sterrice	Sterrice	NNP	B-NP	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
April	April	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
again	again	RB	B-ADVP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
anterior	anterior	JJ	B-NP	O
and	and	CC	I-NP	O
anterolateral	anterolateral	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
mild	mild	JJ	I-NP	O
septal	septal	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
MR.	MR.	NNP	I-NP	O
Cath	Cath	NNP	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
1995	1995	CD	B-NP	O
showed	show	VBD	B-VP	O
three	three	CD	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
four	four	CD	B-NP	O
vessel	vessel	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
with	with	IN	B-PP	O
saphenous	saphenous	JJ	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	B-protein
,	,	,	I-NP	O
OM1	OM1	NN	I-NP	B-protein
and	and	CC	I-NP	O
OM3	OM3	NN	I-NP	B-protein
and	and	CC	O	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ICG	ICG	NN	I-NP	B-protein
placed	place	VBN	B-VP	O
prophylactically	prophylactically	RB	B-ADVP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CABG	CABG	NN	I-NP	O
patch	patch	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
additional	additional	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
report	report	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2000	2000	CD	I-NP	O
in	in	IN	B-PP	O
Ox	Ox	NNP	B-NP	O
News	News	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
hospitalized	hospitalize	VBN	I-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
for	for	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
intubation	intubation	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
September	September	NNP	B-NP	O
2000	2000	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
reportedly	reportedly	RB	I-VP	O
felt	feel	VBN	I-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
difficulty	difficulty	NN	I-NP	O
breathing	breathing	NN	I-NP	O
or	or	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

More	More	RBR	B-ADVP	O
recently	recently	RB	I-ADVP	O
,	,	,	O	O
two	two	CD	B-NP	O
months	month	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
sotalol	sotalol	NN	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
converted	convert	VBD	B-VP	O
.	.	.	O	O

Today	Today	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
electrophysiologist	electrophysiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Handelsman	Handelsman	NNP	I-NP	O
for	for	IN	B-PP	O
routine	routine	JJ	B-NP	O
interrogation	interrogation	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
120s	120	NNS	I-NP	B-DNA
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	NNS	I-NP	O
worsening	worsen	VBG	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
six	six	CD	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
decreased	decrease	VBN	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
palpitations	palpitation	NNS	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
dietary	dietary	JJ	B-NP	O
indiscretion	indiscretion	NN	I-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	I-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
stable	stable	JJ	B-NP	O
two	two	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2000	2000	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
was	be	VBD	B-VP	O
moderately	moderately	RB	I-VP	O
enlarged	enlarge	VBN	I-VP	O
with	with	IN	B-PP	O
depressed	depressed	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
thickened	thicken	VBN	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
or	or	CC	O	O
aortic	aortic	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
mild	mild	JJ	B-NP	I-protein
MR	MR	NN	I-NP	I-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
enlarged	enlarged	JJ	I-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
at	at	IN	B-PP	O
5.7	5.7	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Glyburide	Glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Simvastatin	Simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
upon	upon	IN	B-PP	O
further	further	JJ	B-NP	O
questioning	question	VBG	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
turns	turn	VBZ	B-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
only	only	RB	I-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
sotalol	sotalol	NN	B-NP	O
briefly	briefly	NN	I-NP	O
but	but	CC	O	O
became	become	VBD	B-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
and	and	CC	O	O
so	so	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
20	20	CD	I-NP	O
pack	pack	NN	I-NP	O
year	year	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
and	and	CC	O	O
currently	currently	RB	B-VP	O
continues	continue	VBZ	I-VP	O
with	with	IN	B-PP	O
binge	binge	NN	B-NP	O
drinking	drinking	NN	I-NP	O
of	of	IN	B-PP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
four	four	CD	I-NP	O
whiskey	whiskey	JJ	I-NP	O
drinks	drink	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
in	in	IN	B-PP	O
News	News	NNP	B-NP	O
Ale	Ale	NNP	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
wife	wife	NN	I-NP	O
and	and	CC	I-NP	O
children	child	NNS	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
work	work	NN	B-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
CABG	CABG	NN	I-NP	B-protein
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
his	his	PRP$	B-NP	O
brothers	brother	NNS	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
46	46	CD	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
95.5	95.5	CD	I-NP	I-protein
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
120/80	120/80	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
120	120	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59-year-old	59-year-old	JJ	I-NP	O
male	male	JJ	I-NP	O
male	male	NN	I-NP	O
,	,	,	O	O
well	well	RB	B-VP	O
nourished	nourish	VBN	I-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	NNP	B-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equal	equal	JJ	B-NP	O
,	,	,	I-NP	O
round	round	JJ	I-NP	O
and	and	CC	I-NP	O
reactive	reactive	JJ	I-NP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
are	be	VBP	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
is	be	VBZ	B-VP	O
moist	moist	NN	B-NP	O
.	.	.	O	O

Enlarged	Enlarge	VBN	B-NP	O
bilateral	bilateral	JJ	I-NP	O
submandibular	submandibular	JJ	I-NP	O
glands	gland	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
or	or	CC	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
about	about	IN	B-NP	O
9	9	CD	I-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
wheezes	wheeze	NNS	B-NP	O
or	or	CC	I-NP	O
rales	rale	NNS	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Tachycardic	Tachycardic	JJ	B-ADJP	O
,	,	,	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
3/6	3/6	CD	B-NP	O
holosystolic	holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBN	B-VP	O
best	best	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
,	,	,	O	O
moderately	moderately	RB	B-ADJP	O
distended	distended	JJ	I-ADJP	O
,	,	,	O	O
non-tender	non-tender	JJ	B-ADJP	O
.	.	.	O	O

Incisional	Incisional	JJ	B-NP	O
scars	scar	NNS	I-NP	O
noted	note	VBD	B-VP	O
ventrally	ventrally	RB	B-ADVP	O
and	and	CC	I-ADVP	O
centrally	centrally	RB	I-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
shifting	shift	VBG	I-NP	O
dullness	dullness	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
3	3	CD	I-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
thigh	thigh	NN	B-NP	O
with	with	IN	B-PP	O
notable	notable	JJ	B-NP	O
scrotal	scrotal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
appreciated	appreciate	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

Pedal	Pedal	NNP	B-NP	O
pulses	pulse	VBZ	B-VP	O
not	not	RB	I-VP	O
appreciated	appreciate	VBN	I-VP	O
though	though	IN	B-SBAR	O
.	.	.	O	O

Tibial	Tibial	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
not	not	RB	B-VP	O
appreciated	appreciate	VBN	I-VP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
to	to	TO	B-VP	O
touch	touch	VB	I-VP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Grossly	Grossly	RB	B-ADJP	O
nonfocal	nonfocal	JJ	I-ADJP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
137	137	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
34	34	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.8	1.8	CD	I-NP	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
146	146	CD	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
of	of	IN	B-PP	O
10.2	10.2	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
6.5	6.5	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
44.6	44.6	CD	I-NP	I-protein
.	.	.	O	O

Platelets	Platelet	NNS	B-NP	B-protein
181	181	CD	B-NP	I-protein
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

PTT	PTT	NN	B-NP	O
is	be	VBZ	B-VP	O
26.3	26.3	CD	B-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
0.06	0.06	CD	B-NP	O
.	.	.	O	O

ALT	ALT	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
16	16	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
34	34	CD	I-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
181	181	CD	I-NP	I-cell_line
,	,	,	O	O
T.	T.	NNP	B-NP	O
bili	bili	NNS	I-NP	O
.	.	.	O	O

1.7	1.7	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
protein	protein	NN	I-NP	O
8	8	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
4.7	4.7	CD	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
an	an	DT	B-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
100	100	CD	I-NP	O
to	to	TO	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LDH	LDH	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
RVH	RVH	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST	ST	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
small	small	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
cardiology	cardiology	NN	B-NP	O
service	service	NN	I-NP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
diuresis	diuresis	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
rates	rate	NNS	B-NP	O
between	between	IN	B-PP	O
60	60	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
.	.	.	O	O

His	His	PRP$	B-NP	O
Digoxin	Digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
6.25	6.25	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
CKs	CK	NNS	B-NP	B-protein
of	of	IN	B-PP	O
18	18	CD	B-NP	O
and	and	CC	I-NP	O
124	124	CD	I-NP	O
and	and	CC	O	O
Troponin	Troponin	NN	B-NP	O
of	of	IN	B-PP	O
0.06	0.06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
proceeded	proceed	VBN	B-VP	O
by	by	IN	B-PP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Diuril	Diuril	NNP	B-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
7.5	7.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_type
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
weight	weight	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
88	88	CD	B-NP	O
kg	kg	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
per	per	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
TR	TR	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
15	15	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
from	from	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Marc	Marc	NNP	I-NP	O
R	R	NNP	I-NP	O
Bessick	Bessick	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Eloy	Eloy	NNP	I-NP	O
Williamston	Williamston	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
for	for	IN	B-PP	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
electrical	electrical	JJ	B-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
Lasix	Lasix	NN	I-NP	O
,	,	,	I-NP	O
Zaroxolyn	Zaroxolyn	NN	I-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
previously	previously	RB	I-NP	O
stated	state	VBN	I-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Included	Include	VBD	B-VP	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.	q.	FW	I-NP	O
a.m.	a.m.	FW	I-NP	O
and	and	CC	O	O
160	160	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
p.m.	p.m.	NN	I-NP	O
Glyburide	Glyburide	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Zaroxolyn	Zaroxolyn	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-VP	O
taken	take	VBN	I-VP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
Lasix	Lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Lopressor	Lopressor	NN	B-NP	O
6.25	6.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q	q	NN	I-NP	O
h.s.	h.s.	NN	I-NP	O
Discharge	Discharge	NN	I-NP	O
diet	diet	NN	I-NP	O
is	be	VBZ	B-VP	O
ADA	ADA	JJ	B-NP	O
2000	2000	CD	I-NP	O
kilocalories	kilocalorie	NNS	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
gram	gram	NN	I-NP	O
sodium	sodium	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
1500	1500	CD	B-NP	O
cc	cc	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
SOL	SOL	NNP	B-NP	O
MANASARES	MANASARES	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BH71	BH71	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NOLAN	NOLAN	NNP	B-NP	O
H.	H.	NNP	I-NP	O
WALBRIDGE	WALBRIDGE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ID6	ID6	NNP	I-NP	B-protein
PE248/699094	PE248/699094	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0996	0996	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

W2PGOZ4FII	W2PGOZ4FII	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/8/01	3/8/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/8/01	3/8/01	CD	B-NP	O

